1 September 2010

 

 

 

 

OBN appoints Citigate as its PR Sponsor

 

Citigate to promote OBN’s 5^th Annual BioTrinity Conference

 

Oxford and London – OBN and Citigate Dewe Rogerson (Citigate) announce that Citigate has been appointed as OBN’s PR Sponsor as well as Media and PR Sponsor for OBN’s 5^th Annual BioTrinity Conference, the UK's premier Biopartnering and Investment Conference, to be held on 12-14 April 2011, at Newbury Racecourse, Oxfordshire. Led by Citigate Director Dr. Chris Gardner, members of Citigate’s eight-strong, dedicated Pharma and Biotech team will advise OBN on press, profile and communications issues on an on-going basis, as well as providing PR and media support for BioTrinity 2011.

 

OBN is a not-for-profit business network which provides comprehensive support for biotech and medtech companies in the Oxford and South-East England biocluster and beyond. BioTrinity 2011 will be the largest gathering of the UK's Bioindustry, and is Europe's fastest growing biopartnering and investment conference, facilitating more meetings with more investors than any other UK conference. Partnering activity grew a staggering 70% over 2009/10, with over 1,300 one-to-one meetings taking place over two days between 625 delegates from 415 companies and 19 countries.

 

Citigate’s Pharma and Biotech team has core skills in financial, corporate, scientific and trade PR and works across communications channels and national borders. The team has over 70 years combined experience working with pharma and biotech companies from start-ups to multinationals, providing corporate communications support as well as consultation and execution to deliver successful fundraisings, IPO, M&A transactions, licensing deals and VC exits. The team has also provided PR and media support to high profile industry conferences across Europe.

 

Dr. Jon Rees, OBN’s CEO, said: “Citigate has the perfect mix of experience, industry knowledge and media contacts to advise OBN on its communications and to help promote BioTrinity. We are excited to have appointed such a high-calibre team and look forward to working with them.”

 

Dr. Chris Gardner, Director of Citigate’s Pharma and Biotech team, said: “We are delighted to have been appointed by OBN. OBN’s membership has grown by over 50% in the last 12 months, making it the fastest growing business network in the UK. BioTrinity is proving to be the highlight of the UK’s Spring biotechnology conference calendar and we look forward to working with OBN’s excellent team to build further on this success.”

 

For more information on BioTrinity and to register please visit: www.biotrinity.com

 

To register for a press pass to BioTrinity please contact:

Helena Galilee / Amber Bielecka

Tel: +44 (0)207 282 1052 / 216 4710

helena.galilee@citigatedr.co.uk / amber.bielecka@citigatedr.co.uk

 

 

 

Contacts

 

OBN

Jon Rees, CEO

Tel: +44 (0)845 5049722

jon.rees@obn.org.uk

 

Citigate Dewe Rogerson

Chris Gardner/Helena Galilee/Amber Bielecka                    

T: +44 (0) 20 7638 9571

chris.gardner@citigatedr.co.uk / helena.galilee@citigatedr.co.uk / amber.bielecka@citigatedr.co.uk

 

About OBN

OBN is a not-for-profit business network which provides comprehensive support for biotech and medtech companies in the Oxford and South-East England biocluster and beyond. Our activities can be summarised as networking, partnering, and group purchasing.  Through its delivery of Europe's fastest growing biopartnering and investment conference, BioTrinity, OBN generates more R&D-company-to-investor interactions than anyone else in Europe.  OBN is sponsored by Shire, as Corporate Patron, and Corporate Sponsors MEPC, Manches, James Cowper, Focus, Citigate Dewe Rogerson as well as by its extensive membership of R&D companies and other companies across the entire life sciences industry ecosystem.

 

About Citigate Dewe Rogerson

Citigate Dewe Rogerson is a leading international consultancy specialising in corporate and financial communications. Our mission is to help any company, or organisation, communicate to best effect with all its different audiences, providing high-level strategic media and investor relations consultancy. We are a recognised global leader in international share offer marketing and communications with over 230 offers across 40 countries and $500 billion in proceeds since 1987.  At Citigate Dewe Rogerson we work as an integral part of the advisory team and clients work with consultants who understand not only how markets operate but how opinion is formed.

 

Citigate is headquartered in London and is part of the Huntsworth Group plc.